We compared the top Genetic Tests products so you can quickly spot the strongest options for value, features, and everyday performance.
Offers detailed ethnic origins and ancestry insights.
Provides a comprehensive view of genetic heritage.
User-friendly process with clear, personalized results.
Detailed ancestry and ethnicity insights.
Personalized genetic trait analysis.
Comprehensive ancestry reports provided.
Comprehensive global ancestry exploration included.
Easy-to-use DNA test kit.
Access to extensive historical records.
Comprehensive breed and ancestry information.
Genetic health screening for potential issues.
Connects with relatives through Relative Finder.
Tests for over 350 dog breeds
Provides detailed ancestry and family tree
High accuracy and user-friendly process
Comprehensive insights from over 165 DNA markers.
Includes detailed gut and detoxification reports.
Quick results delivered in just 3-5 weeks.
Comprehensive insights on health and ancestry.
Includes one-year access to exclusive reports.
Valuable personalized genetic information provided.
Identifies over 365 dog breeds accurately.
Screens for 30 genetic health conditions.
Provides detailed ancestry and relative information.
Comprehensive insights on health and ancestry.
Easy-to-understand genetic reports.
User-friendly interface for exploring results.
Genetic testing kits can analyze specific DNA markers from saliva, cheek cells, a cheek swab, or blood samples to provide various insights such as ancestry estimates, matching relatives, trait reports, health risks or carrier status, medication metabolism, fetal sex determination, or breed and inherited condition information in pets. However, the collection method is just the initial step. The accuracy and relevance of the results depend on the specific markers tested, laboratory procedures, reference data for populations or breeds, and whether the interpretation aligns with the intended purpose.
Begin by clarifying your goal. Ancestry estimates are not definitive proofs of nationality or individual ancestors. Relative matches do not determine legal paternity or identity. Carrier or predisposition results focus on selected variants and do not encompass all possible disease-causing mutations. Since targeted genotyping is not equivalent to whole-genome sequencing, a negative result does not rule out untested variants or replace recommended medical screening. For pets, breed composition percentages and inherited risk scores are estimates; health findings are not diagnoses and should not substitute veterinary evaluations.
When it comes to health claims, verify the specific intended use and the variants analyzed. FDA authorization or clearance supports a particular assay or collection device, but does not validate the interpretation of ancestry, traits, breeds, or relative matching. FDA-reviewed direct-to-consumer health reports are limited to specified variants and disclosures. Pharmacogenetic insights should be used as a starting point for consultations with qualified healthcare professionals, not as a basis for decisions to change medications. The American College of Medical Genetics (ACMG) recommends caution in interpreting common MTHFR polymorphisms related to blood clot risk, pregnancy, or supplementation, due to limited clinical utility.
Check that laboratory claims are verifiable. A licensed laboratory with current certifications from CMS CLIA, CAP, A2LA, or ISO standards is more trustworthy than an unnamed “certified lab” or vague accuracy claims. Proper sample handling should include details on collection controls, contamination prevention, quality thresholds, procedures for failed samples or reanalysis, and consistency of results. Claims such as “99% accuracy” may be misleading if based on small or proprietary studies, specific collection methods, limited participant groups, or only certain parts of a broader testing panel.
Results should be presented transparently for verification by professionals. This includes information on the genes or markers tested, variant or genotype notation, measurement methods, report date, uncertainties, reference panel limitations, and raw data if available. Ethnicity and breed estimates, which depend on reference databases, can evolve over time and may be less precise for individuals with mixed backgrounds or for certain breeds or ancestries. Relationship reports should disclose the marker panels used, statistical confidence levels, safeguards against sample mix-ups, and whether collection was supervised. Home collection generally lacks the chain-of-custody required for legal or official purposes such as court cases, immigration, or vital records.
DNA privacy is critical and not easily reversible. Review consent policies related to research, relative matching, data sharing, sample download or deletion, data retention periods, security measures, law enforcement disclosures, and whether data already shared or used in research can be removed. Common warnings across products include cautioning against using results to diagnose illness, alter medications, change diets or supplements, make breeding decisions, or for legal identity verification without professional guidance. Unexpected familial discoveries should be approached with caution; one pet testing product notably experienced a serious sample integrity issue involving human cheek swabs receiving dog breed results in independent investigations.
These criteria differentiate a convenient collection kit from one that provides appropriately limited, technically supported, and practically useful results for responsible follow-up. The scores below are based on the provided reviews and should not replace the product-specific limitations outlined above.
This measure assesses whether the product restricts its recommendations to appropriate uses and advises buyers to consult a healthcare professional or veterinarian before making changes to treatment, screening, breeding, diet, or medication. This is important because many of the products included promote health, supplements, pregnancy, or interpret pet-related risks. Products with higher scores establish clearer boundaries and recommend professional follow-up, while those with lower scores make broader self-management easier, even if disclaimers are included.
This assessment indicates that the specific variants and their interpretations are valuable for the intended purposes, such as determining ancestry, relationships, wellness, health, fetal sex, breed, or veterinary applications. A higher score signifies a more precise claim backed by robust evidence, such as FDA-authorized reports or pertinent veterinary studies. Conversely, lower scores suggest that claims related to diet, supplements, MTHFR, traits, or risks are more general or unsupported by sufficient evidence, or that the reports are not diagnostic.
This assesses the quality of sample collection, analytical accuracy, repeatability, contamination prevention measures, sample quality standards, and procedures for redraws or retests. It is particularly crucial for home-collected saliva, cheek swab, and blood spot samples, where improper technique or sample mix-ups can lead to inaccurate results. Products with higher scores demonstrate compliance with external performance or quality control standards, while the lowest-scoring product was noted for failures related to human sample species identification.
This evaluates whether relationship testing products accurately determine probability limits, prevent sample contamination, disclose chain-of-custody information, and differentiate between private results and legally admissible testing. A high score is achieved through the use of marker-level relationship statistics and, for legal purposes, proper witnessed sample collection and accreditation. Lower scores are typical of home testing kits that may provide personal insights but are not suitable for establishing paternity, identity, immigration status, inheritance rights, or legal evidence.
This assessment covers aspects such as single-use plastics, excess packaging, repeat shipments, return mail materials, disposal instructions, and recycling information. Almost all of the kits provided involve disposable components like swabs, tubes, envelopes, packaging, and mail-back shipping. Typically, a higher score indicates a more streamlined kit or prepaid return process. However, the reviews available offered limited product-specific information regarding recycled materials, material weights, recycling practices, or verified waste-reduction initiatives.
This assesses whether performance and limitations are displayed for specific groups such as ancestry, sex, age, mixed backgrounds, breed, species, or reference panels. This is important because estimates of ancestry percentages, breed identification, and health insights may be less accurate when applied to groups that are underrepresented. Products with higher scores typically feature larger or more relevant data panels and clearly communicate uncertainty, while those with lower scores offer limited evidence of subgroup performance or depend heavily on proprietary databases.
This assesses whether advertising distinguishes between ancestry, traits, predispositions, carrier findings, breed estimates, and wellness information from diagnostic, certainty, or treatment guidance. Higher scores are associated with the use of clear non-medical language, acknowledgment of uncertainty, and clearly stated intended purposes. Conversely, lower scores are given when headlines suggest comprehensive coverage, absolute certainty, or actionable recommendations that are not supported by the available evidence.
This assessment represents an independent verification of the specific test, conducted through FDA records, an accredited laboratory, or peer-reviewed external validation. Achieving a high score requires more than just a brand’s own accuracy claim. Among the products evaluated, higher-rated examples included identifiable FDA-reviewed reports, CAP or AABB listings, or A2LA accreditation. Conversely, lower scores were associated with unnamed laboratories, expired or unlinked records, or evidence authored solely by the manufacturer.
This evaluates whether reports specify the tested markers, genotypes or variants, methodologies used, associated uncertainties, report date, reference ranges, and accessible raw data. Transparent, marker-level details or downloadable data enable clinicians, veterinarians, or qualified laboratories to verify significant findings. Products with lower scores typically offer only general insights, inconsistent marker counts, lack sample reports, do not provide raw data, or do not support reproducibility of interpretations.
This assesses consent and manages aspects such as research participation, matching, sharing, downloading, deletion, sample destruction, security, data retention, and legal disclosures. It is important because genetic information can impact relatives and cannot be entirely recovered once shared or used in research. Products with higher scores offer clear controls for deleting and downloading data, while lower scores indicate broad data permissions, uncertain retention policies, or documented breaches with associated enforcement issues.
This metric evaluates unresolved warnings, recalls, reportable quality actions, adverse event signals, and misleading advertising findings associated with the manufacturer, laboratory, and specific product. A higher score indicates that the review record is relatively clean and well-documented. Conversely, lower scores suggest the presence of warning letters, legal actions related to breaches, post-market reports, or other regulatory indicators. However, if a record pertains to a different product, it should not automatically be considered evidence of failure in this context.
The primary safety advantage lies in scope control. Ancestry’s current terms specify that its DNA results are not intended for medical, diagnostic, law enforcement, paternity, or criminal justice purposes. While its saliva collection device has received FDA 510(k) clearance for DNA specimen collection, this approval does not endorse ethnicity predictions or relative match results as clinical diagnostics. Regarding privacy, Ancestry offers options such as deleting results, downloading raw DNA data, withdrawing consent for future research, and destroying biological samples upon request. However, important limitations exist. Data already used in ongoing or completed research cannot be deleted, and legal obligations may require retention or disclosure of certain information. The company provides a prepaid mailing option to facilitate sample return, reducing the need for separate shipping. Nonetheless, it does not supply detailed information about packaging materials, recycling instructions, or evidence of environmentally friendly packaging, making its environmental impact difficult to verify independently.
This product is designed for adults utilizing DNA as a primary tool for personal genealogy research. It is ideal for those interested in exploring general genetic similarities to reference populations, examining family tree records, or reaching out to potential relatives. It is also suitable for a parent or legal guardian overseeing a minor’s test, following a discussion about sample collection and privacy considerations. Buyers should be comfortable with collecting saliva samples, managing an online account, and understanding that relative matching or ancestry results may uncover surprising family details.
This service is not intended for individuals seeking a diagnosis, medication advice, disease risk evaluation, prenatal information, or confirmation of a genetic condition. Such needs require properly selected clinical testing conducted by a qualified healthcare professional. Additionally, it is not suitable for legal matters such as paternity testing, immigration, inheritance, custody disputes, criminal cases, or identity verification, as sample collection is unsupervised and Ancestry states that its results should not be used for these purposes. People who may find unexpected genetic family discoveries upsetting or who are uncomfortable sharing sensitive genetic information with a commercial company should refrain from using this service for these purposes.
The primary health safeguard is the scope of the product. This product is designed for ancestry, matching, and trait analysis, not for clinical diagnosis or treatment. The FDA states that ancestry tests are not reviewed by the agency, although the saliva collection kit itself has FDA 510(k) clearance. Ancestry claims that its laboratory partners are CLIA-certified and CAP-accredited. However, the publicly available information reviewed here does not independently verify the accuracy of the full ancestry and trait interpretation process for this specific consumer product. DNA results are sensitive and may impact relatives. Ancestry indicates that users can download or delete their DNA data, request the destruction of their samples, adjust matching preferences, and choose whether to participate in research. Its published policies stipulate that disclosure of DNA data requires a legal request, and its 2025 transparency report states that there have been no valid requests for customer DNA data. Deleting data cannot undo information already shared with other users or anonymized data already used in completed research. The saliva tube, packaging, and prepaid return shipping materials are single-use only, and there is no evidence of specific recycling or packaging reduction measures for the product.
This product is ideal for adults seeking a starting point for their personal genealogy research, particularly those interested in exploring broad ancestral region estimates, connecting with potential relatives, and using these clues in conjunction with family records. It is also suitable for users comfortable managing online accounts who acknowledge that ethnicity percentages are probabilistic estimates rather than definitive indicators of nationality, culture, or direct proof of specific ancestors. The product is best suited for situations where discovering unexpected relationships is a possibility and all parties involved have considered the implications for family privacy.
This service is not intended for individuals seeking a diagnosis, disease risk assessment, medication guidance, prenatal information, or confirmation of a suspected inherited condition. Such purposes require a properly ordered clinical test with professional interpretation. Additionally, it is not suitable for paternity testing, inheritance disputes, immigration cases, legal proceedings, or any situation that requires documented chain of custody, as home collection does not constitute legal identity verification. Those who prefer to avoid the potential discovery of unknown relatives or who are uncomfortable with long-term privacy considerations regarding genetic data should refrain from submitting a sample.
The primary safeguard for health with this product is the scope explicitly stated by the company. Ancestry describes its DNA service as genealogical and informational and clearly states that it should not be used for medical, diagnostic, paternity, or legal purposes. FDA records independently confirm that the saliva collection kit associated with the service was approved for use only with Ancestry's separate Factor V Leiden assay. This approval does not mean that ancestry reports are validated as health tests. Ancestry asserts that DNA samples are processed at a secure third-party laboratory in the United States, using an activation code rather than the customer's personal information. The company provides options to download raw data, disable relative matching, delete results, and withdraw consent for biobanking. After doing so, they claim that the remaining sample and any extracted DNA are destroyed. These are the privacy measures stated by the manufacturer; however, they do not eliminate the inherent and irreversible privacy risks of sharing DNA. Additionally, no specific information was found regarding environmentally friendly packaging, recyclable return materials, or instructions for safe disposal.
This product is ideal for adults seeking a consumer genealogy tool to explore extensive ancestral region estimates, develop family history connections, or identify potential DNA relatives. It is best suited for users comfortable managing an online account, reviewing consent options, and understanding that results may evolve as Ancestry updates its reference panels and methodologies. Additionally, it appeals to those who value the ability to download their raw data and have the option to disable matching or delete their results in the future.
This service is not intended for individuals seeking a diagnosis, disease risk assessment, medication guidance, reproductive carrier screening, or results that could influence screening or treatment decisions. Such needs require consultation with a healthcare professional and the use of clinically validated tests. Additionally, it is not suitable for legal paternity, immigration, inheritance, custody, or identity disputes, as this product does not incorporate chain-of-custody procedures and Ancestry strictly prohibits using it for these purposes. Those who may find unexpected relatives or familial matches upsetting, or who cannot accept the long-term privacy implications of sharing genetic data, should avoid using DNA-relative matching features or choosing to test altogether.
Embark states that its processing is conducted in a CLIA-accredited laboratory and outlines several microarray quality control measures. These include multiple probes for detecting mutations, checks for genetic sex, and measures to prevent sample mix-ups. While these safeguards are valuable, the specific accreditation details and scope of testing were not independently verified through public records in this review. Since companion-animal genetic tests do not require FDA approval, no FDA warning letters, recalls, or FTC enforcement actions related to Embark’s tests were found in the publicly available information reviewed. The kit comes with a disposable swab and a prepaid return envelope. Embark claims that samples remain stable for at least six months, which can help reduce the need for repeat collections if mailing is delayed. However, the company does not provide detailed information about the packaging materials, recycling instructions, or a comprehensive waste reduction plan. Consequently, the use of single-use collection and shipping materials presents an environmental concern.
This product is ideal for owners of healthy mixed-breed, rescue, or purebred dogs who want a comprehensive breed and trait profile, along with an extensive inherited-variant screen to discuss with their veterinarian. It is especially useful for those willing to review a detailed report, download raw data, and interpret positive findings as prompts for veterinary consultation rather than as confirmation of illness. Additionally, it is suitable for breeders who require downloadable genotypes and breed-specific reports, as long as the collection identity is independently verified when necessary.
This service is not appropriate for an owner seeking a diagnosis for current symptoms, cancer screening, allergy testing, medication adjustments, or as a substitute for a physical examination and clinical tests. Dogs displaying illness, neurological symptoms, bleeding, eye changes, or suspected drug sensitivities should be evaluated by a veterinarian regardless of test results. Additionally, it is not suitable for legal purposes such as establishing parentage or ownership, resolving disputes, insurance claims, or housing decisions, as the standard consumer collection process does not have a legal chain of custody. Buyers concerned about privacy should review the research and deletion policies carefully.
The main safety benefit of this Breed ID product is its limited scope. It does not provide genetic health-risk results, which helps reduce the risk that owners might mistake a consumer report for a medical diagnosis or change treatment decisions based on the results. Embark recommends consulting a veterinarian or canine health professional for any medical concerns. The company states that its laboratory employs microarray testing and sample quality checks, and that testing is conducted in a CLIA-certified laboratory. However, this certification for the specific assay has not been independently verified through public records or official scope documentation. Embark offers privacy controls at the account level, including options to opt out of research, download raw data, and request the deletion of personal information, subject to certain limitations. Users should be aware that results and samples are sensitive data, and that once used in research, the data cannot be withdrawn. The testing kit includes a disposable swab, tube, packaging, and prepaid return mailer. There is no information available about specific packaging materials, recycling instructions, or waste reduction initiatives, so the environmental impact of disposal and shipping remains unclear.
This product is ideal for dog owners seeking a detailed overview of a mixed-breed dog's ancestry, including a family tree view and potential DNA-relative matches. It is especially useful when the results are used as context for understanding the dog's background or for discussing breed-related questions with a veterinarian, trainer, rescue organization, or breeder. Additionally, it appeals to technically inclined owners who appreciate access to raw genetic marker data and are comfortable with ancestry estimates that tend to be more accurate for well-represented populations, rather than for rare, closely related, or regional landrace breeds.
This product is not intended for individuals seeking a diagnosis, screening for inherited diseases, medication advice, breeding clearance, or as a replacement for veterinary care. It does not include Embark’s genetic health-risk assessment. Additionally, it is not suitable for landlords, insurers, shelters, courts, or regulators requiring legally defensible breed or identity verification, as the standard mail-in cheek swab does not have an established chain of custody. Owners of dogs with ambiguous regional, village-dog, or closely related breed backgrounds should not consider detailed breed percentage results to be definitive.
LifeDNA recognizes Gene by Gene as a genotyping laboratory, and federal FDA documentation confirms that Gene by Gene has operated as a CLIA-certified high-complexity laboratory. While this supports the laboratory's credentials, it does not independently verify the analytical accuracy or health relevance of the specific methylation and wellness product. Additionally, LifeDNA clearly states that its reports are for informational purposes only and are not diagnostic; it recommends consulting a healthcare professional before making significant lifestyle changes. Regarding genetic privacy, protections are considerable but largely depend on LifeDNA’s own policies. The company indicates that participation in research is voluntary (opt-in), customers can request a copy or deletion of their data, and law enforcement disclosures occur only when legally mandated. Its terms also recognize that genetic information involves security risks. No specific packaging details, recycling instructions, return-mailer composition, or sustainability information were found, making it difficult to evaluate the environmental impact of the single-use collection kits and shipping waste.
This product is ideal for adults seeking non-diagnostic, exploratory genetic wellness insights and who understand that the results are not a substitute for medical advice. It is suitable for individuals comfortable with providing a mailed cheek swab, awaiting several weeks for results, and sharing sensitive genetic information with a consumer testing company. However, it is better suited for understanding potential lifestyle implications rather than making medical decisions related to symptoms, pregnancy concerns, clotting risks, medication responses, nutrient deficiencies, or inherited conditions requiring care.
This product is not suitable for individuals attempting to diagnose conditions such as fatigue, depression, digestive issues, infertility, recurrent pregnancy loss, clotting risks, vitamin deficiencies, or inherited disorders. Common MTHFR variants should not replace thorough clinical evaluation, blood tests, or specialized genetic counseling related to specific health conditions. Do not use these results to initiate or discontinue prescription medications, take high-dose supplements, modify pregnancy care, or implement significant dietary changes. Additionally, it is not appropriate for buyers requiring a clinically validated report, verified variant classification, legal identity testing, or comprehensive information on sample and assay quality.
The primary health advantage is that certain Personal Genome Service reports have received FDA marketing authorization. These FDA-reviewed labels restrict the reports to specific genetic variants from adult saliva samples and emphasize that the results are not a substitute for professional medical advice. The pharmacogenetic information provided is intended to facilitate discussions with healthcare providers, rather than to initiate, modify, or discontinue medications. Additionally, the manufacturer offers the option to download raw genetic data; however, this raw data is not a clinical report and should not be interpreted using unverified third-party tools. Privacy is a significant concern. In 2023, a cyberattack exposed data related to approximately 6.9 million customer profiles, leading to multi-state legal actions in 2026. Current policies include features such as two-factor authentication, optional participation in research, the ability to delete accounts, choices regarding sample disposal, and options to share data. Each testing kit includes prepaid return shipping; however, the company does not provide detailed guidance on product-specific recycling or verified packaging materials. The use of single-use collection kits and mail-in return processes results in unavoidable waste.
This product is designed for adults seeking a consumer-oriented ancestry service, along with a curated set of genetic health and medication-metabolism information to review with a healthcare professional. It is ideal for individuals comfortable providing saliva samples by mail, understanding the limitations of the reports, and interpreting the results as helpful insights rather than medical diagnoses. Additionally, it may appeal to buyers who value downloadable genotype data and the option for relative matching, provided they understand that family discoveries can be surprising and that genetic privacy cannot be entirely reversed once data has been shared.
This service is not suitable for individuals seeking diagnosis, extensive hereditary cancer testing, medication guidance, prenatal testing, newborn screening, or legally admissible paternity or identity verification. Those with a personal or strong family history of cancer, clotting disorders, neurological conditions, or inherited diseases should opt for clinician-led testing, which offers more comprehensive gene analysis and professional counseling. Additionally, it is not appropriate for people who are uncomfortable with the privacy risks associated with genetic databases, particularly those concerned about the confirmed data breach in 2023 or the possibility of relatives being identified through matching.
A cheek swab is a noninvasive method, and Wisdom Panel recommends waiting until puppies are weaned to minimize the risk of contamination from maternal milk and other cells. The company’s terms clearly specify limitations for their consumer pet DNA product. They state that the genetic disease screening is not diagnostic, cannot detect all diseases or mutations, and should be used in consultation with a veterinarian rather than for self-diagnosis or treatment decisions. There is a significant privacy consideration. The terms allow for broad use, sharing, or sale of kit materials, samples, results, and pet-related data for research, commercial, statistical, service-improvement, and other lawful purposes. Samples are not returned, and data retention policies may change. The kit requires disposable collection tools and must be mailed back. Although a prepaid return option might make shipping easier, there is no verified information regarding recycled content, recyclability of the mailer, or proper disposal instructions for the materials.
This product is ideal for owners of healthy mixed-breed or rescue dogs who wish to have a structured screening of breed traits, relatives, and limited inherited health conditions to discuss during regular veterinary visits. It is best suited for owners who recognize that breed percentages and behavioral tendencies are approximate estimates, and that any health findings serve as a prompt for professional follow-up rather than a definitive diagnosis. Additionally, it appeals to owners who appreciate having a downloadable detailed report and are comfortable creating an online account to access digital results.
It is not suitable for pet owners to attempt diagnosing symptoms, choosing medications, altering therapeutic diets, or delaying veterinary examinations. Dogs exhibiting neurological signs, bleeding, eye problems, unexplained weight loss, reproductive issues, or a known hereditary condition require assessment and, if necessary, laboratory testing conducted by a veterinarian. Additionally, this service is not intended for legal, pedigree verification, custody disputes, insurance claims, breeding certification, or breed-restriction issues, as the company states that its results are not meant for establishing pedigree or legal proceedings. Households concerned about privacy should carefully review the data terms before submitting a sample.
The method of saliva collection and the selected health reports undergo significant external oversight. FDA marketing authorizations pertain to specific reports and their variations, with the FDA clarifying that pharmacogenetic results should not be used to initiate, modify, or discontinue medications without medical professional guidance. The company affirms that its laboratory testing is conducted in CLIA-certified and CAP-accredited laboratories in the United States; however, this review did not independently verify the current accreditation status through an official directory. Caution is advised when handling DNA data. 23andMe states that users have the ability to download their data, delete their accounts, opt out of research, and request the disposal of stored samples. Despite this, the company reported a security incident to the FTC in 2023, and in May 2026, California’s Attorney General filed a lawsuit against the successor company over alleged security breaches. The testing kit includes a single-use saliva collection container and shipping materials. No independently verified information on the packaging materials or comprehensive recycling instructions was found.
This product is ideal for adults seeking an accessible introduction to their ancestry, with optional genetic-relative matching and a limited selection of regulated health and carrier reports. It is best suited for individuals willing to review report-specific limitations, particularly regarding ancestry relevance, and to discuss any significant positive findings with a healthcare professional such as a physician, genetic counselor, or pharmacist. Additionally, it appeals to users who value the ability to download their genotype data for future professional analysis, while understanding that raw data alone does not constitute a clinical diagnosis.
This service is not intended for individuals seeking a diagnosis, a thorough inherited cancer risk assessment, assistance with medication choices, or reassurance that they do not carry inherited risks. Those with a personal or strong family history of cancer, blood clotting disorders, neurological conditions, inherited blood diseases, or known familial genetic variants should consult a healthcare professional for testing that covers the relevant genes and variants. Additionally, this service is not suitable for legal, court, immigration, inheritance, or paternity cases, as it does not offer documented identity verification or a legal chain of custody. Privacy-conscious households should carefully consider the potential privacy implications before using this service.
